We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Saia
SAIA
$11.3B
| $7.49M | 0.01% |
15,792
+14,892
| +1,655% | +$6.94M |
|
827
Edgewise Therapeutics
EWTX
$4.39B
| $7.49M | 0.01% |
415,720
+361,103
| +661% | +$6.3M |
|
828
Hess Midstream
HESM
$5.22B
| $7.46M | 0.01% |
204,660
-183,259
| -47% | -$6.47M |
|
|
ONC
829
BeOne Medicines Ltd
ONC
$33.8B
| $7.42M | 0.01% |
51,987
-52,428
| -50% | -$8.08M |
|
|
FISV
830
Fiserv Inc
FISV
$27.2B
| $7.32M | 0.01% |
49,124
-17,535
| -26% | -$2.65M |
|
831
Silicon Motion
SIMO
$9.19B
| $7.31M | 0.01% |
90,317
-15,252
| -14% | -$1.19M |
|
|
STR
832
DELISTED
Sitio Royalties
STR
| $7.29M | 0.01% |
308,752
+297,928
| +2,752% | +$7.01M |
|
|
VSTO
833
DELISTED
Vista Outdoor Inc.
VSTO
| $7.29M | 0.01% |
193,610
+185,181
| +2,197% | +$6.39M |
|
834
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
| $7.29M | 0.01% |
289,108
-1,157,012
| -80% | -$27.3M |
|
|
CYBR
835
DELISTED
CyberArk
CYBR
| $7.27M | 0.01% |
26,605
-254,050
| -91% | -$62.4M |
|
836
Avery Dennison
AVY
$12.3B
| $7.26M | 0.01% |
33,193
+6,632
| +25% | +$1.47M |
|
837
PUT
Palo Alto Networks
PANW
$264B
| $7.25M | 0.01% |
42,800
-164,200
| -79% | -$24.6M |
|
838
enGene Therapeutics
ENGN
$122M
| $7.21M | 0.01% |
764,645
-35,355
| -4% | -$454K |
|
839
Arcos Dorados Holdings
ARCO
$1.73B
| $7.13M | 0.01% |
+792,035
| New | +$8.15M |
|
|
VTLE
840
DELISTED
Vital Energy
VTLE
| $7.11M | 0.01% |
158,648
-99,701
| -39% | -$4.97M |
|
841
AMN Healthcare
AMN
$1.28B
| $7.08M | 0.01% |
138,253
-139,444
| -50% | -$7.9M |
|
842
Hyatt Hotels
H
$17.6B
| $7.07M | 0.01% |
+46,565
| New | +$6.99M |
|
843
Walt Disney
DIS
$165B
| $7.07M | 0.01% |
71,156
-71,616
| -50% | -$7.71M |
|
844
Philip Morris
PM
$301B
| $7.03M | 0.01% |
69,394
-97,187
| -58% | -$9.5M |
|
845
Clearfield
CLFD
$421M
| $7.03M | 0.01% |
182,277
-2,732
| -1% | -$94.9K |
|
846
New Oriental
EDU
$7.84B
| $7.01M | 0.01% |
90,156
-262,556
| -74% | -$21.4M |
|
847
CALL
Advanced Micro Devices
AMD
$851B
| $6.99M | 0.01% |
43,100
+28,900
| +204% | +$4.65M |
|
|
CGAU
848
Centerra Gold
CGAU
$3.22B
| $6.97M | 0.01% |
1,037,839
+504,636
| +95% | +$3.31M |
|
849
OSI Systems
OSIS
$3.57B
| $6.97M | 0.01% |
50,700
-126,776
| -71% | -$17.5M |
|
850
Edwards Lifesciences
EW
$47.6B
| $6.9M | 0.01% |
74,666
-104,328
| -58% | -$9.24M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.